日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer.

以溃疡分枝杆菌细胞色素bc(1):aa(3)为靶点治疗布鲁里溃疡

Scherr Nicole, Bieri Raphael, Thomas Sangeeta S, Chauffour Aurélie, Kalia Nitin Pal, Schneide Paul, Ruf Marie-Thérèse, Lamelas Araceli, Manimekalai Malathy S S, Grüber Gerhard, Ishii Norihisa, Suzuki Koichi, Tanner Marcel, Moraski Garrett C, Miller Marvin J, Witschel Matthias, Jarlier Vincent, Pluschke Gerd, Pethe Kevin

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms

对溃疡分枝杆菌病(布鲁里溃疡)的易感性与IFNG和iNOS基因多态性相关

Bibert, Stéphanie; Bratschi, Martin W; Aboagye, Samuel Y; Collinet, Emilie; Scherr, Nicole; Yeboah-Manu, Dorothy; Beuret, Christian; Pluschke, Gerd; Bochud, Pierre-Yves

Comparative Study of Activities of a Diverse Set of Antimycobacterial Agents against Mycobacterium tuberculosis and Mycobacterium ulcerans

对多种抗分枝杆菌药物对抗结核分枝杆菌和溃疡分枝杆菌的活性进行比较研究

Scherr, Nicole; Pluschke, Gerd; Panda, Manoranjan

Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment

塞拉菌素是治疗布鲁里溃疡最有潜力的阿维菌素类药物。

Scherr, Nicole; Pluschke, Gerd; Thompson, Charles J; Ramón-García, Santiago

Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis

结核分枝杆菌毒力因子蛋白激酶G特异性抑制的结构基础

Scherr, Nicole; Honnappa, Srinivas; Kunz, Gabriele; Mueller, Philipp; Jayachandran, Rajesh; Winkler, Fritz; Pieters, Jean; Steinmetz, Michel O